Table of Contents

Executive Summary

1 Angiogenesis Modulators Market Overview

• 1.1 Product Overview and Scope of Angiogenesis Modulators
• 1.2 Angiogenesis Modulators Segment by Type
  • 1.2.1 Global Angiogenesis Modulators Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Angiogenesis Inhibitors
  • 1.2.3 Angiogenesis Stimulators
  • 1.2.4 Angiogenin
  • 1.2.5 Others
• 1.3 Angiogenesis Modulators Segment by Application
  • 1.3.1 Angiogenesis Modulators Consumption Comparison by Application (2014-2025)
  • 1.3.2 Breast Cancer
  • 1.3.3 Colorectal Cancer
  • 1.3.4 Lung Cancer
  • 1.3.5 Prostate Cancer
  • 1.3.6 Others
• 1.3 Global Angiogenesis Modulators Market by Region
  • 1.3.1 Global Angiogenesis Modulators Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Angiogenesis Modulators Market Size
  • 1.4.1 Global Angiogenesis Modulators Revenue (2014-2025)
  • 1.4.2 Global Angiogenesis Modulators Production (2014-2025)

2 Global Angiogenesis Modulators Market Competition by Manufacturers

• 2.1 Global Angiogenesis Modulators Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Angiogenesis Modulators Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Angiogenesis Modulators Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Angiogenesis Modulators Production Sites, Area Served, Product Types
• 2.5 Angiogenesis Modulators Market Competitive Situation and Trends
  • 2.5.1 Angiogenesis Modulators Market Concentration Rate
  • 2.5.2 Angiogenesis Modulators Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Angiogenesis Modulators Production Market Share by Regions

• 3.1 Global Angiogenesis Modulators Production Market Share by Regions
• 3.2 Global Angiogenesis Modulators Revenue Market Share by Regions (2014-2019)
• 3.3 Global Angiogenesis Modulators Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Angiogenesis Modulators Production
  • 3.4.1 North America Angiogenesis Modulators Production Growth Rate (2014-2019)
  • 3.4.2 North America Angiogenesis Modulators Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Angiogenesis Modulators Production
  • 3.5.1 Europe Angiogenesis Modulators Production Growth Rate (2014-2019)
  • 3.5.2 Europe Angiogenesis Modulators Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Angiogenesis Modulators Production (2014-2019)
  • 3.6.1 China Angiogenesis Modulators Production Growth Rate (2014-2019)
  • 3.6.2 China Angiogenesis Modulators Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Angiogenesis Modulators Production (2014-2019)
  • 3.7.1 Japan Angiogenesis Modulators Production Growth Rate (2014-2019)
  • 3.7.2 Japan Angiogenesis Modulators Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Angiogenesis Modulators Consumption by Regions

• 4.1 Global Angiogenesis Modulators Consumption by Regions
• 4.2 North America Angiogenesis Modulators Consumption (2014-2019)
• 4.3 Europe Angiogenesis Modulators Consumption (2014-2019)
• 4.4 China Angiogenesis Modulators Consumption (2014-2019)
• 4.5 Japan Angiogenesis Modulators Consumption (2014-2019)

5 Global Angiogenesis Modulators Production, Revenue, Price Trend by Type

• 5.1 Global Angiogenesis Modulators Production Market Share by Type (2014-2019)
• 5.2 Global Angiogenesis Modulators Revenue Market Share by Type (2014-2019)
• 5.3 Global Angiogenesis Modulators Price by Type (2014-2019)
• 5.4 Global Angiogenesis Modulators Production Growth by Type (2014-2019)

6 Global Angiogenesis Modulators Market Analysis by Applications

• 6.1 Global Angiogenesis Modulators Consumption Market Share by Application (2014-2019)
• 6.2 Global Angiogenesis Modulators Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Angiogenesis Modulators Business

• 7.1 Celgene Corporation (USA)
  • 7.1.1 Celgene Corporation (USA) Angiogenesis Modulators Production Sites and Area Served
  • 7.1.2 Angiogenesis Modulators Product Introduction, Application and Specification
  • 7.1.3 Celgene Corporation (USA) Angiogenesis Modulators Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Eisai Co., Ltd. (Japan)
  • 7.2.1 Eisai Co., Ltd. (Japan) Angiogenesis Modulators Production Sites and Area Served
  • 7.2.2 Angiogenesis Modulators Product Introduction, Application and Specification
  • 7.2.3 Eisai Co., Ltd. (Japan) Angiogenesis Modulators Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Amgen, Inc. (USA)
  • 7.3.1 Amgen, Inc. (USA) Angiogenesis Modulators Production Sites and Area Served
  • 7.3.2 Angiogenesis Modulators Product Introduction, Application and Specification
  • 7.3.3 Amgen, Inc. (USA) Angiogenesis Modulators Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Genentech, Inc. (USA)
  • 7.4.1 Genentech, Inc. (USA) Angiogenesis Modulators Production Sites and Area Served
  • 7.4.2 Angiogenesis Modulators Product Introduction, Application and Specification
  • 7.4.3 Genentech, Inc. (USA) Angiogenesis Modulators Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 GlaxoSmithKline plc (UK)
  • 7.5.1 GlaxoSmithKline plc (UK) Angiogenesis Modulators Production Sites and Area Served
  • 7.5.2 Angiogenesis Modulators Product Introduction, Application and Specification
  • 7.5.3 GlaxoSmithKline plc (UK) Angiogenesis Modulators Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Bayer Pharma AG (Germany)
  • 7.6.1 Bayer Pharma AG (Germany) Angiogenesis Modulators Production Sites and Area Served
  • 7.6.2 Angiogenesis Modulators Product Introduction, Application and Specification
  • 7.6.3 Bayer Pharma AG (Germany) Angiogenesis Modulators Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Bionomics Ltd. (Australia)
  • 7.7.1 Bionomics Ltd. (Australia) Angiogenesis Modulators Production Sites and Area Served
  • 7.7.2 Angiogenesis Modulators Product Introduction, Application and Specification
  • 7.7.3 Bionomics Ltd. (Australia) Angiogenesis Modulators Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 CASI Pharmaceuticals, Inc. (USA)
  • 7.8.1 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Production Sites and Area Served
  • 7.8.2 Angiogenesis Modulators Product Introduction, Application and Specification
  • 7.8.3 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 AstraZeneca plc (UK)
  • 7.9.1 AstraZeneca plc (UK) Angiogenesis Modulators Production Sites and Area Served
  • 7.9.2 Angiogenesis Modulators Product Introduction, Application and Specification
  • 7.9.3 AstraZeneca plc (UK) Angiogenesis Modulators Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Eli Lilly and Company (USA)
  • 7.10.1 Eli Lilly and Company (USA) Angiogenesis Modulators Production Sites and Area Served
  • 7.10.2 Angiogenesis Modulators Product Introduction, Application and Specification
  • 7.10.3 Eli Lilly and Company (USA) Angiogenesis Modulators Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 F.Hoffmann-La Roche AG (Switzerland)

8 Angiogenesis Modulators Manufacturing Cost Analysis

• 8.1 Angiogenesis Modulators Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Angiogenesis Modulators
• 8.4 Angiogenesis Modulators Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Angiogenesis Modulators Distributors List
• 9.3 Angiogenesis Modulators Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Angiogenesis Modulators Market Forecast

• 11.1 Global Angiogenesis Modulators Production, Revenue Forecast
  • 11.1.1 Global Angiogenesis Modulators Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Angiogenesis Modulators Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Angiogenesis Modulators Price and Trend Forecast (2019-2025)
• 11.2 Global Angiogenesis Modulators Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Angiogenesis Modulators Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Angiogenesis Modulators Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Angiogenesis Modulators Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Angiogenesis Modulators Production, Revenue Forecast (2019-2025)
• 11.3 Global Angiogenesis Modulators Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Angiogenesis Modulators Consumption Forecast (2019-2025)
  • 11.3.2 Europe Angiogenesis Modulators Consumption Forecast (2019-2025)
  • 11.3.3 China Angiogenesis Modulators Consumption Forecast (2019-2025)
  • 11.3.4 Japan Angiogenesis Modulators Consumption Forecast (2019-2025)
• 11.4 Global Angiogenesis Modulators Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Angiogenesis Modulators Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

The global Angiogenesis Modulators market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Angiogenesis Modulators volume and value at global level, regional level and company level. From a global perspective, this report represents overall Angiogenesis Modulators market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Celgene Corporation (USA)
Eisai Co., Ltd. (Japan)
Amgen, Inc. (USA)
Genentech, Inc. (USA)
GlaxoSmithKline plc (UK)
Bayer Pharma AG (Germany)
Bionomics Ltd. (Australia)
CASI Pharmaceuticals, Inc. (USA)
AstraZeneca plc (UK)
Eli Lilly and Company (USA)
F.Hoffmann-La Roche AG (Switzerland)

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Angiogenesis Inhibitors
Angiogenesis Stimulators
Angiogenin
Others

Segment by Application
Breast Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer
Others